Turkey Tail
The mushroom behind PSK and PSP — the only fungal polysaccharides registered in Japan as drugs supporting chemotherapy. Among the most solid clinical evidence of any functional mushroom, but this is NOT a standalone cancer therapy.
Number of studies
2
Safety
Requires caution
Time to effects
Immunomodulatory effects in studies were usually assessed after several to a dozen or so weeks of regular use.
Monthly cost
ok. 100–180 zł/miesiąc
Price in Poland
100–180 zł za 90–120 kapsułek ekstraktu
Who it's for
Ceny rosną wraz ze standaryzacją zawartości polisacharydów (30%+) i certyfikatami czystości.
Indicative prices for the Polish market — we don't point to specific retailers; the real price depends on the manufacturer, form and place of purchase.
Table of contents
TL;DR
The mushroom behind PSK and PSP — the only fungal polysaccharides registered in Japan as drugs supporting chemotherapy. Among the most solid clinical evidence of any functional mushroom, but this is NOT a standalone cancer therapy.
- →Studied as adjuvant therapy alongside chemotherapy in gastrointestinal cancers — mainly in Japanese studies using pharmaceutical-grade PSK, not dietary supplements
- →May support immune parameters in some cancer patients during and after treatment
- →A rich source of beta-glucans with potential general immunostimulatory activity
| Latin name | Trametes versicolor (syn. Coriolus versicolor) |
|---|---|
| Family | Polyporaceae (bracket fungi) |
| Active compounds | PSK (polysaccharide-K, Krestin), PSP (polysaccharide peptide), beta-glucans |
| Form | Water extract from the fruiting body or mycelium, standardized to polysaccharide content (≥20–30%) |
| Level of evidence | Moderate — among the strongest evidence of any functional mushroom |
| Interactions | Immunosuppressants, chemotherapy, anticoagulants, hypoglycemic drugs |
| Status | A dietary supplement in Poland and the EU; PSK/Krestin is a registered oncology drug in Japan |
Understand
Overview
Turkey tail (Trametes versicolor, synonym Coriolus versicolor), also known as many-colored polypore — named for its characteristic, fan-shaped, concentrically banded fruiting body resembling a spread turkey tail — is one of the most common bracket fungi in the world, growing in Poland on dead deciduous wood almost everywhere. In Chinese and Japanese medicine it has been used for centuries as an ingredient in immune-boosting blends.
Turkey tail stands out among functional mushrooms in that it isn't the subject of preliminary preclinical research alone — two patented polysaccharide preparations have been isolated from its mycelium, PSK (polysaccharide-K, known in Japan under the trade name Krestin) and PSP, which since the 1970s and 1980s have been registered drugs in Japan used as adjuvant therapy alongside standard chemotherapy for cancers of the stomach, colon, esophagus, and lungs. It's worth emphasizing, though: PSK/PSP are not registered as a drug in Poland or the EU, and the turkey tail extracts available in Polish stores are dietary supplements, not equivalents of the Japanese pharmaceutical-grade drug.
Who genuinely benefits from turkey tail, and who doesn't? The strongest data concerns cancer patients undergoing treatment for gastrointestinal and lung cancers, using PSK as an addition to chemotherapy under oncologist supervision — this is the only group for which hard data from randomized trials exists. People seeking general immune support outside an oncology context can expect at most an effect similar to other beta-glucan sources. Turkey tail will NOT work as a standalone cancer therapy and does not replace chemotherapy or radiotherapy.
Where it's found
Turkey tail is one of the most common bracket fungi in the world. In Poland it grows commonly on dead and decaying deciduous wood (beech, oak, birch), forming characteristic, fan-shaped, tile-like clusters of fruiting bodies on trunks and stumps year-round.
History of use
The use of turkey tail in traditional Chinese and Japanese medicine goes back centuries — it was used in herbal blends as an immune-boosting agent (known in Japan as "kawaratake"). A breakthrough came in the 1960s and 1970s, when Japanese researchers isolated PSK from the mycelium, leading to the registration of the Krestin preparation as an oncology drug supporting chemotherapy.
Mechanism of action
PSK and PSP are protein-bound polysaccharides (proteoglycans) that in laboratory and clinical studies show immunomodulatory activity — they stimulate the activity of T lymphocytes, NK cells, and macrophages, and affect cytokine production (including IL-2, IFN-gamma). In tumor models, pro-apoptotic activity against cancer cells has also been described. In clinical studies, the clinical effect (extended survival) was observed mainly as an addition to chemotherapy, not as a standalone therapy — the mechanism is best understood as supporting the immune system of a patient weakened by cancer treatment.
At the molecular level, the beta-glucans that make up PSK/PSP are recognized by the Dectin-1 receptor and Toll-like receptors (TLR2/TLR4) on macrophages and dendritic cells, which triggers the NF-κB and MAPK signaling pathways, leading to dendritic cell maturation and more effective presentation of tumor antigens to T lymphocytes. Additionally, PSK has been described as capable of partly breaking down the immunosuppressive tumor microenvironment — among other things by limiting excessive activity of regulatory T cells (Tregs).
Recognition of beta-glucans
The Dectin-1 receptor and Toll-like receptors (TLR2/TLR4) on macrophages and dendritic cells bind the PSK/PSP polysaccharides.
Activation of NF-κB and MAPK pathways
Receptor binding triggers a signaling cascade leading to the maturation of immune cells.
Stimulation of the immune response
Increased activity of T lymphocytes, NK cells, and cytokine production (IL-2, IFN-gamma).
Reduction of tumor immunosuppression
Described reduction of Treg activity within the tumor microenvironment.
Clinical effect as an adjuvant
Extended survival observed in studies only as an addition to chemotherapy, not as a standalone therapy.
Evidence: moderate — based on 2 studies in this database.
Benefits
Common myths
MythTurkey tail cures cancer
FactNo study has shown that turkey tail alone cures cancer. The clinical data concerns PSK as an ADDITION to standard chemotherapy, extending survival in some cancers — not as a replacement for cancer treatment
MythA store-bought supplement works the same as the Japanese drug PSK/Krestin
FactPSK is a patented, standardized pharmaceutical used in clinical trials. Dietary supplements made from turkey tail available in Poland can have a completely different profile and concentration of active compounds.
Forms & variants
Turkey Tail comes in several forms that differ in bioavailability and use case — the form you pick genuinely matters for how effective the supplementation is.
Water extract from the fruiting body (standardized to polysaccharides)
The most commonly studied form, close to the material used in Asian studies
Best for: People looking for the form closest to what's been scientifically studied
Powdered mycelial biomass (grown on grain substrate)
A cheaper form, but usually with lower and less predictable active polysaccharide content than fruiting body extract
Best for: Budget-conscious general immune support, when maximum standardization isn't the priority
PSK / Krestin (pharmaceutical drug)
A registered prescription oncology drug available in Japan — not available in Poland or the EU
Best for: Not applicable to the Polish market — listed to distinguish it from supplements sold under the turkey tail name
Practice
Frequently asked questions
No. No study indicates that turkey tail or PSK can replace standard cancer treatment. The available data concerns exclusively its use as an addition to chemotherapy, under medical supervision, mainly in studies from Japan. Abandoning conventional treatment in favor of a supplement is dangerous.
This isn't recommended. Although Japanese studies combined PSK with chemotherapy, they did so within a tightly controlled clinical protocol. Adding a dietary supplement to cancer treatment on your own, without the oncologist's knowledge, could affect the therapy's effectiveness — always consult the treating physician first.
These are different mushrooms with different uses: turkey tail is studied mainly for immune support and as an oncology adjuvant (PSK/PSP), while lion's mane is studied for its effect on nerve growth factor (NGF) and cognitive function.
Dosage & timing
Typical dose
1000–3000 mg of fruiting body/mycelium extract daily (supplements); clinical studies with pharmaceutical PSK used doses on the order of 3000 mg/day
Form
Capsules or powder from a water extract, standardized to polysaccharide content (usually ≥20–30%)
People with cancer or taking oncology drugs should consult use of turkey tail only with their treating physician — the dietary supplement available in Poland is not an equivalent of the drug PSK/Krestin registered in Japan.
Best times to take it
- Split into 2–3 doses throughout the day, with food, for better gastric tolerance
What to combine with
Good combinations
Lion's Mane — A common combination in mushroom stacks aimed at immunity and recovery
Cordyceps militaris — A popular pairing supporting immunity and energy
Safety
Side effects & contraindications
Possible side effects
Generally well tolerated in clinical studies, including at high doses
Possible gastrointestinal complaints at higher doses
Rarely: allergic reactions in people allergic to mushrooms
No long-term safety data for dietary supplements at doses comparable to pharmaceutical PSK
Contraindications
Pregnancy and breastfeeding (insufficient data)
Mushroom allergy
Autoimmune diseases — caution warranted due to immunostimulatory activity
People undergoing cancer treatment: use ONLY after consultation with, and under supervision of, the treating oncologist — turkey tail never replaces chemotherapy, radiotherapy, or other cancer therapy
Planned surgery — discontinuation in advance is recommended
Interactions
Immunosuppressants — potential antagonism of effect; medical consultation required
Chemotherapy and other oncology drugs — combining the supplement with cancer treatment without a doctor's knowledge is discouraged
Anticoagulant and antiplatelet drugs — theoretical interaction risk
Blood sugar-lowering drugs — possible additive hypoglycemic effect
Is it worth taking?
Who it's for
- People looking for well-documented, scientifically supported immune support in their daily supplementation
- Cancer patients considering supportive supplementation — only after consulting the physician managing their treatment
Not for
- Pregnancy and breastfeeding (insufficient data)
- Mushroom allergy
- Autoimmune diseases — caution warranted due to immunostimulatory activity
- People undergoing cancer treatment: use ONLY after consultation with, and under supervision of, the treating oncologist — turkey tail never replaces chemotherapy, radiotherapy, or other cancer therapy
- Planned surgery — discontinuation in advance is recommended
Evidence
Worth knowing
PSK (Krestin), isolated from turkey tail, was at one point one of the best-selling oncology drugs in Japan
The name "turkey tail" comes from the concentric, multicolored bands on the fruiting body, resembling a spread turkey's tail
Studies
In a randomized trial of 262 patients after gastric cancer resection, adding PSK to standard treatment improved 5-year overall survival and recurrence-free survival.
Nakazato H. et al., The Lancet, 1994
Efficacy of immunochemotherapy as adjuvant treatment after curative resection of gastric cancer
Moderate evidenceNakazato H, Koike A, Saji S, Ogawa N, Sakamoto J · The Lancet · 1994
A randomized trial of 262 patients after gastric cancer resection showed that adding PSK to standard treatment improved 5-year recurrence-free survival and 5-year overall survival compared with standard treatment alone.
View studyPhase 1 Clinical Trial of Trametes versicolor in Women with Breast Cancer
Early-stage evidenceTorkelson CJ, Sweet E, Martzen MR, Sasagawa M, Wenner CA, Gay J, Putiri A, Standish LJ · ISRN Oncology · 2012
A phase 1 trial in 11 women with breast cancer after completing radiotherapy showed that oral doses of Trametes versicolor extract up to 9 g/day for 6 weeks were safe and well tolerated.
View studySources & bibliography
- Examine.com — Turkey Tail / Coriolus versicolor
- National Cancer Institute (PDQ) — Medicinal Mushrooms
Citations are illustrative for this demo version and require full bibliographic verification by the editorial team before production publication.
Compare with similar entries
About the authors of this entry
Author
dr Piotr ZielińskiEndocrinologist
Piotr reviews content on hormones, metabolic health and supplement pharmacology.
131 publications on this site
Medical review
dr Anna KowalczykEditor-in-Chief, Molecular Biology
Anna oversees the editorial process and scientific review of every publication in the knowledge base. She previously researched autophagy and mitochondrial biology.
50 publications on this site
Related entries
4.4Lion's Mane
A functional mushroom studied for its effect on nerve growth factor (NGF) and cognitive function — human evidence is still preliminary.
4.1Cordyceps militaris
A laboratory-cultivated functional mushroom — this is the species behind almost every 'cordyceps' supplement sold today. High, stable cordycepin content, but evidence for improved physical performance in humans is still mixed.
4.1Mesima (Phellinus linteus)
A tree-growing mushroom from Korea and Japan, sold commercially as Mesima — one of the few functional mushrooms with real, randomized clinical trials in humans assessing effects on immunity, not just in-vitro data.
3.7Split Gill (Schizophyllan)
One of the most common mushroom species on Earth, whose polysaccharide (SPG) is a registered injectable drug in Japan used as an adjunct to radiotherapy for cervical cancer. In Poland and the EU it is neither a registered drug nor a dietary supplement.
4.3Shiitake
A culinary-functional mushroom rich in lentinan and beta-glucans, studied clinically for immune modulation and lipid profile — one of the best-researched functional mushrooms on the market.
4.3Oyster Mushroom (Pleurotus ostreatus)
One of the most popular edible mushrooms in Poland, containing a natural compound structurally similar to lovastatin — studied mainly for its effects on lipid profile and immunity.
4.2Reishi (Ganoderma lucidum)
A functional mushroom with more than 2,000 years of history in Chinese and Japanese medicine, studied for its immune-modulating effects — human clinical evidence, however, remains modest and partly contradictory.
4.1Almond Mushroom (Agaricus blazei)
A mushroom from the Brazilian forests studied mainly for immune modulation and blood-sugar support — human evidence is mixed and preliminary, despite the supplement's considerable popularity.
Related articles
Opinie ekspertówFunctional Mushroom Ranking: Which Ones Have the Strongest Scientific Evidence
Reishi, shiitake, lion's mane, cordyceps, chaga... The VitMode knowledge base covers more than 50 species of medicinal mushrooms. We picked the five with the most solid evidence base and ranked them by specific use case.
August 18, 2026
PoradnikiCold Showers and Immunity: Do You Really Get Sick Less?
"Cold exposure boosts your immune system" is one of the most repeated claims in biohacking — but the newest, largest meta-analysis on the topic shows something more complex: inflammation rises short-term, and immune markers don't budge. There is, though, one real, if surprising, long-term effect. We break down the evidence.
August 22, 2026
PoradnikiZinc and the Common Cold: Does It Really Shorten It?
"Zinc shortens colds" is one of the oldest claims in supplementation — and one of the few backed by meta-analyses with concrete numbers. But this story has an instructive plot twist: part of the key Cochrane evidence was withdrawn over data errors. We break down the topic, including what you shouldn't trust uncritically.
August 22, 2026
PoradnikiVitamin C and the Common Cold: Does the Pauling Myth Hold Up?
Two-time Nobel laureate Linus Pauling argued in the 1970s that megadoses of vitamin C could prevent the common cold — a belief that still drives supplement sales worldwide today. The largest Cochrane review, covering over 11,000 participants, tells a far more nuanced story: for the average person, regular vitamin C supplementation barely moves the needle on catching a cold. But there's a clear exception — and the data behind it is some of the strongest in the entire review.
August 23, 2026
Comments (2)
- KW
Kasia W. 2 weeks ago
Very clearly explained, especially the interactions section — I hadn't seen it laid out this well anywhere else.
- MT
Marek T. a month ago
Are you planning to update this with the newest study from this year? I saw an interesting meta-analysis.